Kathleen E Sullivan1, Maire Conrad2, Judith R Kelsen2. 1. The Division of Allergy Immunology. 2. The Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: Immune dysregulation disorders are among the most rapidly growing set of inborn errors of immunity. One particular subset is the category where early-onset inflammatory bowel disease (IBD) is the most common manifestation. These disorders are being increasingly appreciated although there has been minimal effort to articulate a unified approach to their diagnosis and management. This review will cover current thinking and strategies related to diagnosis and management of very early-onset IBD. RECENT FINDINGS: There is an expanding set of monogenic causes of early-onset IBD. In many cases, the precise genetic cause dictates management. Lessons learned from the management of these monogenic conditions can sometimes be extrapolated to other refractory cases of IBD. SUMMARY: An integrated approach to diagnosis, risk analysis, and management can include diagnostic approaches not often utilized for traditional IBD such as whole exome sequencing. Management can also include nontraditional approaches such as targeted biologics or hematopoietic cell transplantation.
PURPOSE OF REVIEW: Immune dysregulation disorders are among the most rapidly growing set of inborn errors of immunity. One particular subset is the category where early-onset inflammatory bowel disease (IBD) is the most common manifestation. These disorders are being increasingly appreciated although there has been minimal effort to articulate a unified approach to their diagnosis and management. This review will cover current thinking and strategies related to diagnosis and management of very early-onset IBD. RECENT FINDINGS: There is an expanding set of monogenic causes of early-onset IBD. In many cases, the precise genetic cause dictates management. Lessons learned from the management of these monogenic conditions can sometimes be extrapolated to other refractory cases of IBD. SUMMARY: An integrated approach to diagnosis, risk analysis, and management can include diagnostic approaches not often utilized for traditional IBD such as whole exome sequencing. Management can also include nontraditional approaches such as targeted biologics or hematopoietic cell transplantation.
Authors: Matthew R Hepworth; Thomas C Fung; Samuel H Masur; Judith R Kelsen; Fiona M McConnell; Juan Dubrot; David R Withers; Stephanie Hugues; Michael A Farrar; Walter Reith; Gérard Eberl; Robert N Baldassano; Terri M Laufer; Charles O Elson; Gregory F Sonnenberg Journal: Science Date: 2015-04-23 Impact factor: 47.728
Authors: Amanda Ricciuto; Jennifer R Fish; Diane E Tomalty; Nicholas Carman; Eileen Crowley; Cynthia Popalis; Aleixo Muise; Thomas D Walters; Anne M Griffiths; Peter C Church Journal: Arch Dis Child Date: 2017-08-09 Impact factor: 3.791
Authors: Matthew R Kudelka; Benjamin H Hinrichs; Trevor Darby; Carlos S Moreno; Hikaru Nishio; Christopher E Cutler; Jianmei Wang; Huixia Wu; Junwei Zeng; Yingchun Wang; Tongzhong Ju; Sean R Stowell; Asma Nusrat; Rheinallt M Jones; Andrew S Neish; Richard D Cummings Journal: Proc Natl Acad Sci U S A Date: 2016-12-07 Impact factor: 11.205
Authors: Kwang Yeon Kim; Eun Joo Lee; Ju Whi Kim; Jin Soo Moon; Ju Young Jang; Hye Ran Yang; Jae Sung Ko Journal: Pediatr Gastroenterol Hepatol Nutr Date: 2018-01-12
Authors: Holm H Uhlig; Fabienne Charbit-Henrion; Daniel Kotlarz; Dror S Shouval; Tobias Schwerd; Caterina Strisciuglio; Lissy de Ridder; Johan van Limbergen; Marina Macchi; Scott B Snapper; Frank M Ruemmele; David C Wilson; Simon P L Travis; Anne M Griffiths; Dan Turner; Christoph Klein; Aleixo M Muise; Richard K Russell Journal: J Pediatr Gastroenterol Nutr Date: 2021-03-01 Impact factor: 3.288
Authors: Chrissy Bolton; Nicola Burch; James Morgan; Beth Harrison; Sumeet Pandey; Alistair T Pagnamenta; Jenny C Taylor; John M Taylor; Judith C W Marsh; Victoria Potter; Simon Travis; Holm H Uhlig Journal: J Crohns Colitis Date: 2020-01-01 Impact factor: 9.071